Skip to main content
. 2023 Jan 2;6(1):46–55. doi: 10.1136/bmjnph-2022-000544

Table 3.

Norwood practice data on T2D remission March 2015–April 2021

Data collected
to:
Mean duration of low-carbohydrate approach No of T2D cases in remission
HbA1c<48*
No of choosing the approach Remission rate for people who choose the low-carbohydrate approach No of patients with T2D on the diabetic register Overall remission rate for practice
March 2017 13 months 15 48 31% 416 4%
May 2018 20 months 41 106 39% 454 9%
January 2019 22 months 59 123 48% 469 13%
March 2020 30 months 68 143 48% 485 14%
April 2021 33 months 94 186 51% 473 20%

*T2D remission defined as: previous diagnosis of T2D by WHO criteria and HbA1c <6.5% (<48 mmol/mol) without antidiabetes medication. As per McCombie et al. 39 in mmol/mol.

HbA1c, Glycated haemoglobin; T2D, type 2 diabetes.